4.7 Article

Continuous 24-Hour Leptin, Proopiomelanocortin, and Amino Acid Measurements in Human Cerebrospinal Fluid: Correlations With Plasma Leptin, Soluble Leptin Receptor, and Amino Acid Levels

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 99, Issue 7, Pages 2540-2548

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1210/jc.2013-4087

Keywords

-

Funding

  1. NIH [RO1-DK093920]
  2. Robert C. and Veronica Atkins Foundation Consortium
  3. Washington University Nutrition Obesity Research Center [DK 56341]
  4. New York Nutrition Obesity Research Center [DK 26687]
  5. Michigan Nutrition Obesity Research Center [DK089503]
  6. Michigan Regional Comprehensive Metabolomics Resource Core [U24-DK097153]
  7. A. Alfred Taubman Institute
  8. [K23-AG0309460]
  9. [R01-NS065667]
  10. [DK 37948]

Ask authors/readers for more resources

Context: In order to characterize diurnal changes in central leptin and its target neuropeptide, proopiomelanocortin (POMC), we measured leptin and POMC in cerebrospinal fluid (CSF) as related to changes in plasma leptin and soluble leptin receptor (sOB-R) levels. CSF and plasma levels of 20 amino acids (AA) were also measured because AA can affect brain POMC. Design and Participants: Stored CSF and plasma samples obtained from eight healthy subjects who served as controls for a previous study were evaluated. CSF was collected hourly over 33 h via indwelling subarachnoid catheter. Leptin, sOB-R, and POMC were measured by sensitive ELISA and AA by gas chromatography-mass spectrometry. Results: There was a diurnal rhythm for plasma leptin with a peak at 2200 h (144% of baseline) and there was a similar diurnal rhythm for CSF leptin with a peak (117%) 3-5 h after the plasma peak. Plasma sOB-R was lowest at 0300 h and correlated negatively with plasma and CSF leptin. A diurnal rhythm for POMC in CSF was also detected with a peak (125%) at 0100 h. A positive correlation existed between CSF POMC and leptin in individual subjects over time. CSF levels of many AA increased at night. There was a significant correlation between CSF POMC and 10 AA, including leucine, isoleucine, tryptophan, and tyrosine. Conclusions: Diurnal changes occur in leptin and POMC in human CSF that likely reflect changes in central leptin and melanocortin activity. Our results suggest that nocturnal elevations in leptin, AA, and POMC may help to suppress appetite and feeding at night.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance

Alexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, Jeffrey L. Dage, Randall J. Bateman, Henrik Zetterberg, Kaj Blennow, Erik Stomrud, Niklas Mattsson-Carlgren, Oskar Hansson

Summary: This study found that creatinine and body mass index are associated with certain plasma biomarker levels, but they do not have clinically relevant confounding effects for the majority of individuals.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Acute sleep loss decreases CSF-to-blood clearance of Alzheimer's disease biomarkers

Haiyan Liu, Nicolas R. Barthelemy, Vitaliy Ovod, James G. Bollinger, Yingxin He, Samir L. Chahin, Brendan Androff, Randall J. Bateman, Brendan P. Lucey

Summary: Sleep deprivation increases cerebrospinal fluid (CSF) amyloid beta (Aβ) and tau levels, while decreasing plasma levels. These findings suggest that sleep loss affects plasma biomarkers of Alzheimer's disease and should be taken into account when interpreting individual plasma biomarkers.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with A beta-PET, neurodegeneration, and cognition

Pratishtha Chatterjee, Lisa Vermunt, Brian A. Gordon, Steve Pedrini, Lynn Boonkamp, Nicola J. Armstrong, Chengjie Xiong, Abhay K. Singh, Yan Li, Hamid R. Sohrabi, Kevin Taddei, Mark Molloy, Tammie L. S. Benzinger, John C. Morris, Celeste Karch, Sarah Berman, Jasmeer Chhatwal, Carlos Cruchaga, Neill R. Graff-Radford, Gregory S. Day, Martin Farlow, Nick Fox, Alison Goate, Jason Hassenstab, Jae-Hong Lee, Johannes Levin, Eric McDade, Hiroshi Mori, Richard Perrin, Raquel Sanchez-Valle, Peter R. Schofield, Allan Levey, Mathias Jucker, Colin L. Masters, Anne M. Fagan, Randall J. Bateman, Ralph N. Martins, Charlotte Teunissen

Summary: This study found that plasma GFAP levels increase a decade before symptom onset in AD and are associated with Aβ load, neurodegeneration, and cognitive decline.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease

Chengjie Xiong, Lena M. McCue, Virginia Buckles, Elizabeth Grant, Folasade Agboola, Dean Coble, Randall J. Bateman, Anne M. Fagan, Tammie L. S. Benzinger, Jason Hassenstab, Suzanne E. Schindler, Eric McDade, Krista Moulder, Brian A. Gordon, Carlos Cruchaga, Gregory S. Day, Takeshi Ikeuchi, Kazushi Suzuki, Ricardo F. Allegri, Jonathan Voeglein, Johannes Levin, John C. Morris

Summary: This study compared biomarkers of late-onset Alzheimer's disease (LOAD) and autosomal dominant AD (ADAD). The results showed that at baseline, ADAD mutation carriers (MCs) had lower CSF A beta 42 levels and higher levels of total and phosphorylated tau-181, and PiB uptake compared to LOAD participants with a positive family history (FH+). Longitudinally, MCs had a similar increase in PiB uptake to FH+, but a much faster decline in hippocampal volume, and were the only group showing cognitive decline.

ALZHEIMERS & DEMENTIA (2023)

Article Endocrinology & Metabolism

Prospective Test Performance of Nonfasting Biomarkers to Identify Dysglycemia in Children and Adolescents

Mary Ellen Vajravelu, Emily Hirschfeld, Acham Gebremariam, Charles F. Burant, William H. Herman, Karen E. Peterson, Jennifer L. Meijer, Joyce M. Lee

Summary: This study evaluated the prospective test performance of different screening measures for identifying dysglycemia in youth. The results showed that HbA1c and nonfasting glucose tests had reasonable longitudinal discrimination in identifying adolescents at risk for dysglycemia, but their performance depended on the definition of the outcome.

HORMONE RESEARCH IN PAEDIATRICS (2023)

Article Medicine, General & Internal

Lecanemab in Early Alzheimer's Disease

Christopher H. van Dyck, Chad J. Swanson, Paul Aisen, Randall J. Bateman, Christopher Chen, Michelle Gee, Michio Kanekiyo, David Li, Larisa Reyderman, Sharon Cohen, Lutz Froelich, Sadao Katayama, Marwan Sabbagh, Bruno Vellas, David Watson, Shobha Dhadda, Michael Irizarry, Lynn D. Kramer, Takeshi Iwatsubo

Summary: Lecanemab, a humanized monoclonal antibody, reduced amyloid markers and showed improvement in cognition and function in early Alzheimer's disease patients. However, it also resulted in adverse events. Longer trials are needed to determine its efficacy and safety in early Alzheimer's disease.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Biology

Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study

Peter R. Millar, Brian A. Gordon, Patrick H. Luckett, Tammie L. S. Benzinger, Carlos Cruchaga, Anne M. Fagan, Jason J. Hassenstab, Richard J. Perrin, Suzanne E. Schindler, Ricardo F. Allegri, Gregory S. Day, Martin R. Farlow, Hiroshi Mori, Georg Nuebling, Randall J. Bateman, John C. Morris, Beau M. Ances

Summary: Estimates of 'brain-predicted age' quantify apparent brain age compared to normative trajectories of neuroimaging features. The brain age gap (BAG) between predicted and chronological age is elevated in symptomatic Alzheimer disease (AD) but has not been well explored in presymptomatic AD. Prior studies have typically modeled BAG with structural MRI, but more recently other modalities, including functional connectivity (FC) and multimodal MRI, have been explored.

ELIFE (2023)

Article Clinical Neurology

Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease

Kanta Horie, Yan R. Li, Nicolas Barthelemy, Brian Gordon, Jason Hassenstab, Tammie L. S. M. Benzinger, Anne C. Fagan, John M. Morris, Celeste Karch, Chengjie Xiong, Ricardo Allegri, Patricio Chrem Mendez, Takeshi Ikeuchi, Kensaku Kasuga, James Noble, Martin Farlow, Jasmeer Chhatwal, Gregory R. Day, Peter R. Schofield, Colin Masters, Johannes Levin, Mathias Jucker, Jae-Hong Lee, Jee Hoon Roh, Chihiro Sato, Pallavi Sachdev, Akihiko Koyama, Larisa J. Reyderman, Randall Bateman, Eric McDade

Summary: Identifying cerebrospinal fluid measures of the microtubule binding region of tau (MTBR-tau) species that reflect tau aggregation could provide fluid biomarkers that track Alzheimer's disease related neurofibrillary tau pathological changes.

ANNALS OF NEUROLOGY (2023)

Article Genetics & Heredity

Evaluation of polygenic risk scores to differentiate between type 1 and type 2 diabetes

Muhammad Shoaib, Qiang Ye, Heidi IglayReger, Meng H. H. Tan, Michael Boehnke, Charles F. F. Burant, Scott A. A. Soleimanpour, Sarah A. Gagliano A. Taliun

Summary: Polygenic risk scores (PRS) can quantify the genetic susceptibility to disease by analyzing summary statistics from genome-wide association studies (GWAS). Differentiating between type 1 (T1D) and type 2 (T2D) diabetes accurately is crucial for diagnosis and treatment. PRS have the potential to address misclassification of T1D and T2D.

GENETIC EPIDEMIOLOGY (2023)

Article Endocrinology & Metabolism

Metabolic dysfunction in obesity is related to impaired suppression of fatty acid release from adipose tissue by insulin

Michael W. W. Schleh, Benjamin J. J. Ryan, Cheehoon Ahn, Alison C. C. Ludzki, Pallavi Varshney, Jenna B. B. Gillen, Douglas W. W. Van Pelt, Lisa M. M. Pitchford, Suzette M. M. Howton, Thomas Rode, Thomas L. L. Chenevert, Scott L. L. Hummel, Charles F. F. Burant, Jeffrey F. F. Horowitz

Summary: The objective of this study was to assess the relationship between insulin-mediated glucose uptake and clinical outcomes, as well as deep-phenotyping measures. The study also aimed to examine how adipocyte size, fibrosis, and proteomic profile contribute to the regulation of fatty acid rate of appearance.

OBESITY (2023)

Article Cell Biology

Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic 0 cells

Weiwei Xu, M. M. Fahd Qadir, Daniela Nasteska, Paula Mota de Sa, Caroline M. Gorvin, Manuel Blandino-Rosano, Charles R. Evans, Thuong Ho, Evgeniy Potapenko, Rajakrishnan Veluthakal, Fiona B. Ashford, Stavroula Bitsi, Jia Fan, Manika Bhondeley, Kejing Song, Venkata N. Sure, Siva S. V. P. Sakamuri, Lina Schiffer, Wandy Beatty, Rachael Wyatt, Daniel E. Frigo, Xiaowen Liu, Prasad V. Katakam, Wiebke Arlt, Jochen Buck, Lonny R. Levin, Tony Hu, Jay Kolls, Charles F. Burant, Alejandra Tomas, Matthew J. Merrins, Debbie C. Thurmond, Ernesto Bernal-Mizrachi, David J. Hodson, Franck Mauvais-Jarvis

Summary: Male mice without androgen receptor (AR) in pancreatic 0 cells have reduced insulin secretion and develop hyperglycemia. Testosterone activates an extranuclear AR, which enhances glucagon-like peptide-1 (GLP-1) insulin action. This study investigates the mechanisms through which testosterone enhances GLP-1-stimulated insulin secretion in male 0 cells, including the activation of cAMP production and the recruitment of Gas to GLP-1 receptor and AR complexes. Additionally, testosterone promotes insulin secretion in human islets through an actin remodeling cascade. The study provides insights into the genomic and non-genomic actions of AR in regulating insulin exocytosis.

CELL REPORTS (2023)

Article Neurosciences

Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease

Jan Krzysztof Blusztajn, Nurgul Aytan, Thekkelnaycke Rajendiran, Tiffany J. Mellott, Tanu Soni, Charles F. Burant, Geidy E. Serrano, Thomas G. Beach, Honghuang Lin, Thor D. Stein

Summary: This study identified monogalactosyl diglycerides (MGDGs) as a central correlate of clinical and pathological progression in Alzheimer's disease (AD). The levels of MGDGs were found to be positively associated with AD-related traits in postmortem brain samples. These findings suggest the importance of MGDG metabolism in the progression of AD.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Cell Biology

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease

Nicolas R. Barthelemy, Benjamin Saef, Yan Li, Brian A. Gordon, Yingxin He, Kanta Horie, Erik Stomrud, Gemma Salvado, Shorena Janelidze, Chihiro Sato, Vitaliy Ovod, Rachel L. Henson, Anne M. Fagan, Tammie L. S. Benzinger, Chengjie Xiong, John C. Morris, Oskar Hansson, Randall J. Bateman, Suzanne E. Schindler

Summary: CSF tau phosphorylation at T217 and T205 sites is a better marker for Alzheimer's disease pathology than current tests.

NATURE AGING (2023)

Article Cell Biology

Human striatal glia differentially contribute to AD- and PD-specific neurodegeneration

Jinbin Xu, Huifangjie L. Farsad, Yiran Hou, Kia Barclay, Ben Anthony Lopez, Shinnosuke Yamada, Ibrahim Olabayode Saliu, Yiming Shi, William C. Knight, Randall J. Bateman, Tammie L. S. Benzinger, Jason J. Yi, Qingyun Li, Ting Wang, Joel S. Perlmutter, John C. Morris, Guoyan Zhao

Summary: Zhao et al. discovered evolutionarily conserved astrocyte and microglia subpopulations shared across multiple brain regions, revealing similarities and differences in AD and PD glia and regional variance linked to AD pathology and neurodegeneration. Their analysis identified commonalities between AD and PD astrocytes and unique transcriptomic changes in microglia for each disorder. They also delineated undescribed subpopulations of medium spiny neurons (MSNs) and provided neuronal transcriptomic profiles suggesting disease-specific changes and selective vulnerability.

NATURE AGING (2023)

No Data Available